| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |